Concepedia

Safety Subgroup Analysis

Safety Subgroup Analysis is a statistical evaluation method used in clinical or comparative safety studies that identifies differential safety profiles of interventions within specific subpopulations defined by baseline characteristics, thereby distinguishing it from overall safety assessment by focusing on heterogeneous treatment effects across predefined subgroups.

422

Publications

19.9K

Citations

4.6K

Authors

1.8K

Institutions

Publications per year

2017–2026

237

Parents

Publications

422

How to Use a Subgroup Analysis

Xin Sun, John P. A. Ioannidis, Thomas Agoritsas et al. · JAMA · 2014 · 547 citations

, , +15

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Antonio L. Dans, Stuart J. Connolly, Lars Wallentin et al. · Circulation · 2012 · 480 citations · Full text

, , +17

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

Hans‐Christoph Diener, Stuart J. Connolly, Michael D. Ezekowitz et al. · The Lancet Neurology · 2010 · 454 citations

, , +14

Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration

David S. Boyer, Andrew N. Antoszyk, Carl C. Awh et al. · Ophthalmology · 2007 · 396 citations

, , +12

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

Graeme J. Hankey, Manesh R. Patel, Susanna R. Stevens et al. · The Lancet Neurology · 2012 · 353 citations

, , +13

1–5 of 422

Authors

4.6K

  1. SY
    Salim Yusuf

    McMaster University, Canada

    8 publications · 1.6K citations

    8

    h-index

  2. HU
    Hirotsugu Uemura

    Kindai University, Japan

    7 publications · 236 citations

    6

    h-index

  3. RJ
    Robert J. Motzer

    Memorial Sloan Kettering Cancer Center, United States

    6 publications · 173 citations

    6

    h-index

  4. KM
    Kei Muro

    Aichi Cancer Center, Japan

    6 publications · 279 citations

    6

    h-index

  5. BI
    Brian I. Rini

    Cleveland Clinic, United States

    5 publications · 143 citations

    5

    h-index

1–5 of 4.6K

Institutions

1.8K

  1. Pfizer (United States)

    New York, United States

    16 h-index

    47 publications

    1.9K citations

  2. Stanford University

    Stanford, United States

    15 h-index

    34 publications

    3K citations

  3. Harvard University

    Cambridge, United States

    14 h-index

    36 publications

    3.5K citations

  4. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    14 h-index

    16 publications

    687 citations

  5. Assistance Publique – Hôpitaux de Paris

    Paris, France

    13 h-index

    47 publications

    2.1K citations

  6. Memorial Sloan Kettering Cancer Center

    New York, United States

    13 h-index

    21 publications

    612 citations

  7. National Cancer Center Hospital East

    Kashiwa, Japan

    13 h-index

    28 publications

    765 citations

  8. Eli Lilly (United States)

    Indianapolis, United States

    12 h-index

    30 publications

    1.3K citations

1–8 of 1.8K

Venues

  1. Journal of Clinical Oncology

    14 publications · 380 citations

    12

    h-index

  2. PubMed

    Repository · 11 publications · 359 citations

    10

    h-index

  3. Annals of Oncology

    10 publications · 343 citations

    10

    h-index

  4. The Lancet Neurology

    8 publications · 2.2K citations

    8

    h-index

  5. Diabetes Obesity and Metabolism

    8 publications · 219 citations

    8

    h-index

1–5